Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine for prevention of postoperative delirium in surgical ICU patients
IRCT20210523051374N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Caffeine with Placebo (2 arms). Primary endpoint: Delirium in the first 3 days after admission to the intensive care unit. Started Jun 2024; status: completed.
02
Drugs
caffeine
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20210523051374N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210523051374N1.